                               SEQUENCE LISTING

<110>  Roche Diagnostics GmbH
       F. Hoffmann-La Roche AG
 
<120> ENRICHMENT OF FULL-LENGTH OLIGONUCLEOTIDES VIA 
      TRANSCRIPTION/TRANSLATION-MEDIATED PURIFICATION

<130> P31918-WO

<140>
<141>

<150> 61/922,267
<151> 2013-12-31

<160> 18    

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 1
tgccggagtc agcgt                                                        15


<210> 2
<211> 15
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 2
agtcagagtc gccac                                                        15


<210> 3
<211> 64
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 3
taatacgact cactataggg ttaactttag taaggaggac agctaaatgt gccggagtca       60

gcgt                                                                    64


<210> 4
<211> 65
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 4
taatacgact cactataggg ttaactttag taaggaggac agctaaatgc tgccggagtc       60

agcgt                                                                   65


<210> 5
<211> 66
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 5
taatacgact cactataggg ttaactttag taaggaggac agctaaatgc ctgccggagt       60

cagcgt                                                                  66


<210> 6
<211> 70
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 6
tttttttttt tcaaactgcg gatggctcca acttatcgtc gtcatctttg tagtcagtca       60

gagtcgccac                                                              70


<210> 7
<211> 45
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 7
ttttttctta tcgtcgtcat ctttgtagtc agtcagagtc gccac                       45


<210> 8
<211> 49
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 8
taatacgact cactataggg ttaactttag taaggaggac agctaaatg                   49


<210> 9
<211> 55
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 9
tttttttttt tcaaactgcg gatggctcca acttatcgtc gtcatctttg tagtc            55


<210> 10
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 10
ttttttctta tcgtcgtcat ctttgtagtc                                        30


<210> 11
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 11
Asp Tyr Lys Asp Asp Asp Asp Lys 
1               5               


<210> 12
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 12
Trp Ser His Pro Gln Phe Glu Lys 
1               5               


<210> 13
<211> 169
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 13
taatacgact cactataggg ttaactttag taaggaggac agctaaatgt gccggagtca       60

gcgtcctcat cctcatggaa tctccacttg gtgcggggat agacatttga tgcagggaga      120

acaggtggcg actctgactg actacaaaga tgacgacgat aagaaaaaa                  169


<210> 14
<211> 192
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 14
taatacgact cactataggg ttaactttag taaggaggac agctaaatgt gccggagtca       60

gcgtcctcat cctcatggaa tctccacttg gtgcggggat agacatttga tgcagggaga      120

acaggtggcg actctgactg actacaaaga tgacgacgat aagttggagc catccgcatt      180

tgaaaaaaaa aa                                                          192


<210> 15
<211> 48
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 15
Met Cys Arg Ser Gln Arg Pro His Pro His Gly Ile Ser Thr Trp Cys 
1               5                   10                  15      


Gly Asp Arg His Leu Met Gln Gly Glu Gln Val Ala Thr Leu Thr Asp 
            20                  25                  30          


Tyr Lys Asp Asp Asp Asp Lys Leu Glu Pro Ser Ala Val Lys Lys Lys 
        35                  40                  45              


<210> 16
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 16
tgccggagtc agcgtcctca tcct                                              24


<210> 17
<211> 90
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 17
tgccggagtc agcgtcctca tcctcatgga atctccactt ggtgcgggga tagacatttg       60

atgcagggag aacaggtggc gactctgact                                        90


<210> 18
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 18
ggagaacagg tggcgactct gact                                              24


